Evidence map›Paper›PMID 39058308›Full record

ArticleJournal of the Pediatric Infectious Diseases Society2024

Durations of Antibiotic Treatment for Acute Otitis Media and Variability in Prescribed Durations Across Two Large Academic Health Systems.

Sophie E Katz, Timothy C Jenkins, Amy B Stein, Gale Thomas, Nancy Koenig, Gary Lucas Starnes, Jason G Newland, Ritu Banerjee, Holly M Frost

Abstract read
In one paragraph

Article in Journal of the Pediatric Infectious Diseases Society, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Incidence of mastoiditis complications in relation to prior community-based antibiotic treatment.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Sophie E KatzDivision of Infectious Diseases, Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Timothy C JenkinsDivision of Infectious Diseases, Department of Medicine, Denver Health and Hospital Authority, Denver, Colorado, USA.
Amy B SteinCenter for Health Systems Research, Denver Health and Hospital Authority, Denver, Colorado, USA.
Gale ThomasDivision of Infectious Diseases, Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Nancy KoenigDivision of Infectious Diseases, Department of Pediatrics, Washington University in St. Louis, St. Louis, Missouri, USA.
Gary Lucas StarnesDivision of Infectious Diseases, Department of Pediatrics, Washington University in St. Louis, St. Louis, Missouri, USA.
Jason G NewlandDivision of Infectious Diseases, Department of Pediatrics, Washington University in St. Louis, St. Louis, Missouri, USA.
Ritu BanerjeeDivision of Infectious Diseases, Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Holly M FrostCenter for Health Systems Research, Denver Health and Hospital Authority, Denver, Colorado, USA.ORCID 0000-0002-3016-3287

Funding

RELAX: Reducing Length of Antibiotics For Children With Ear InfectionsR01HS029153 · AHRQ · IHC HEALTH SERVICES, INC. · PI Holly Frost · 2022 to 2026
$2.3M
Agency for Healthcare Research and QualityAHRQ HHS R01 HS029153U.S. Department of Health and Human Services 1R01HS029153-01
6 · The paper itself

Abstract

backgroundAcute otitis media (AOM) accounts for roughly 25% of antibiotics prescribed to children annually. Despite national guidelines that recommend short (5-7 days) durations of antibiotics for children 2 years and older with AOM, most receive long (10 day) courses. This study aims to evaluate antibiotic durations prescribed for children aged 2-17 years with uncomplicated AOM across two pediatric academic health systems, and to assess the variability in prescribed durations between and within each system.

methodsElectronic medical record data from 135 care locations at two health systems were retrospectively analyzed. Outpatient encounters for children aged 2-17 years with a diagnosis of AOM from 2019 to 2022 were included. The primary outcome was the percent of 5-day prescriptions. Secondary outcomes included the proportion of 7-day prescriptions, 10-day prescriptions, prescriptions for nonfirst-line antibiotics, cases associated with treatment failure, AOM recurrence, and adverse drug events.

resultsAmong 73 198 AOM encounters for children 2 years and older, 61 612 (84%) encounters resulted in an antibiotic prescription. Most prescriptions were for 10 days (45 689; 75%), 20% were for 7 days (12 060), and only 5% were for 5 days (3144). Treatment failure, AOM recurrence, adverse drug events, hospitalizations, and office, emergency department or urgent-care visits for AOM within 30 days after the index visit were rare.

conclusionsDespite national guidelines that recommend shorter durations for children with uncomplicated AOM, 75% of our cohort received 10-day durations. Shortening durations of therapy for AOM could reduce antibiotic exposure and should be a priority of pediatric antibiotic stewardship programs.

Indexed as

Anti-Bacterial AgentsOtitis MediaPractice Patterns, Physicians'Academic Medical CentersAcute DiseaseAdolescentAntimicrobial StewardshipChildChild, PreschoolDrug Administration ScheduleElectronic Health RecordsFemaleHumansMaleRetrospective StudiesAnti-Bacterial Agentsacute otitis mediaantibiotic stewardshipduration of therapypediatrics

Identifiers

PMID39058308
PMCPMC11424993

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.